Tower Research Capital LLC (TRC) - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 64 filers reported holding NEOS THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 3.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$13,000
-13.3%
24,969
+13.3%
0.00%
-100.0%
Q2 2020$15,000
-16.7%
22,043
-9.5%
0.00%0.0%
Q1 2020$18,000
-33.3%
24,349
+36.3%
0.00%
-50.0%
Q4 2019$27,000
+35.0%
17,864
+31.7%
0.00%
+100.0%
Q3 2019$20,000
+185.7%
13,562
+146.6%
0.00%
Q2 2019$7,000
-66.7%
5,500
-30.7%
0.00%
-100.0%
Q1 2019$21,000
+2000.0%
7,935
+1487.0%
0.00%
Q4 2018$1,000
-97.9%
500
-94.8%
0.00%
-100.0%
Q3 2018$47,000
+123.8%
9,703
+289.5%
0.00%
+50.0%
Q1 2018$21,000
+110.0%
2,491
+117.6%
0.00%
+100.0%
Q3 2017$10,0001,1450.00%
Q2 2017$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q1 2017$22,000
+4.8%
3,017
-16.7%
0.00%0.0%
Q4 2016$21,000
+133.3%
3,622
+271.1%
0.00%
+100.0%
Q2 2016$9,000
+50.0%
976
+69.4%
0.00%0.0%
Q1 2016$6,000
-89.7%
576
-79.3%
0.00%
-83.3%
Q3 2015$58,0002,7810.01%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,858,889$7,337,0005.11%
Proxima Capital Management, LLC 170,294$257,0000.77%
SPHERA FUNDS MANAGEMENT LTD. 3,530,731$5,331,0000.44%
Nantahala Capital Management 4,610,000$6,961,0000.21%
Wealthstar Advisors, LLC 73,295$111,0000.07%
Alambic Investment Management, L.P. 51,733$78,0000.06%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 100,000$151,0000.05%
BCS Wealth Management 29,520$45,0000.03%
Allred Capital Management, LLC 24,995$37,742,0000.02%
ALGERT GLOBAL LLC 34,254$52,0000.02%
View complete list of NEOS THERAPEUTICS INC shareholders